AnandRathi

Glaxosmithkline Pharmaceuticals Ltd Fundamental Analysis

Last Updated Date: 27 Aug 2026
3,068.35
+40.85 (+1.35%)

Glaxosmithkline Pharmaceuticals Ltd (Glaxosmi. Pharma) fundamental analysis breaks down the key financial metrics of the mid-cap Pharmaceuticals company, which carries a market capitalisation of ₹51,980 crore.

Glaxosmithkline Pharmaceuticals Ltd Overview

Market cap₹51,980 Crs
Volume6,205
Prev. Close₹3,027.50
Year range₹2,088.00 - ₹3,051.00
Total Value₹1,90,39,111.75
ISININE159A01016

Glaxosmithkline Pharmaceuticals Ltd Fundamental Analysis

ROCE(TTM)60.63%
P/E Ratio (TTM)49.02
P/B Ratio23.19
Debt to Equity0.01
ROE45.15%
EPS (TTM)62.48
Dividend Yield1.86%
Book Value132.30
Profit Margin27.07%
Operating Margin32.63%

Glaxosmithkline Pharmaceuticals Ltd Historical Performance

1 Month Return20.32%
6 Month Return19.39%
3 Year Return118.12%
3 Month Return33.35%
1 Year Return10.05%
5 Year Return101.46%

Glaxosmithkline Pharmaceuticals Ltd Share Price History

High:0.00
Low:0.00
No History Available

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research